Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts

World Journal of Gastroenterology

Volumn 15, Issue 31, 2009, Pages 3931-3936

  Liu, Fei ^a   Li, Ya ^b   Lan, Xiang ^a   Wei, Yong Gang ^a   Li, Bo ^a   Yan, Lv Nan ^a   Wen, Tian Fu ^a   Zhao, Ji Chun ^a   Xu, Ming Qing ^a   Wang, Wen Tao ^a   Yang, Jia Yin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Blood concentration; Liver transplantation; Living donor; Small for size graft; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AGED; ARTICLE; BODY WEIGHT; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; ORGAN SIZE; TREATMENT OUTCOME;

ADULT; AGED; BODY WEIGHT; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350516389     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3931     Document Type: Article

References (28)

1. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Fulcher AS, Posner MP. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-1379 (Pubitemid 30238727)
2. Humar A, Kosari K, Sielaff TD, Glessing B, Gomes M, Dietz C, Rosen G, Lake J, Payne WD. Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl 2004; 10: 374-378
3. Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Lyn Price L, Lewis WD, Jenkins RL. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 2003; 76: 5-10 (Pubitemid 36877107)
4. Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation 2008; 85: 554-560
5. Taber DJ, Dupuis RE, Fann AL, Andreoni KA, Gerber DA, Fair JH, Johnson MW, Shrestha R. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. Liver Transpl 2002; 8: 219-223 (Pubitemid 34257203)
6. Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29: 404-430
7. Kishino S, Ogawa M, Takekuma Y, Sugawara M, Shimamura T, Furukawa H, Todo S, Miyazaki K. The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipients. Clin Transplant 2004; 18: 124-129 (Pubitemid 38404640)
8. Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 2001; 57: 479-484 (Pubitemid 32930148)
9. Kishino S, Takekuma Y, Sugawara M, Shimamura T, Furukawa H, Todo S, Miyazaki K. Influence of continuous venovenous haemodiafiltration on the pharmacokinetics of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transplant 2003; 17: 412-416 (Pubitemid 37236112)
10. Todo S, Fung JJ, Tzakis A, Demetris AJ, Jain A, Alessiani M, Takaya S, Day R, Gordon R, Starzl TE. One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc 1991; 23: 1397-1402
11. Yasuhara M, Hashida T, Toraguchi M, Hashimoto Y, Kimura M, Inui K, Hori R, Inomata Y, Tanaka K, Yamaoka Y. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. Transplant Proc 1995; 27: 1108-1110
12. Whitington PF, Kehrer BH, Whitington SH, Shneider B, Black DD. The effect of biliary enteroenterostomy on the pharmacokinetics of enterally administered cyclosporine in rats. Hepatology 1989; 9: 393-397 (Pubitemid 19074970)
13. Marcos A, Olzinski AT, Ham JM, Fisher RA, Posner MP. The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation. Transplantation 2000; 70: 1697-1703 (Pubitemid 32064822)
14. Smyrniotis V, Kostopanagiotou G, Kondi A, Gamaletsos E, Theodoraki K, Kehagias D, Mystakidou K, Contis J. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int 2002; 15: 355-360 (Pubitemid 36068189)
15. Payen DM, Fratacci MD, Dupuy P, Gatecel C, Vigouroux C, Ozier Y, Houssin D, Chapuis Y. Portal and hepatic arterial blood flow measurements of human transplanted liver by implanted Doppler probes: interest for early complications and nutrition. Surgery 1990; 107: 417-427 (Pubitemid 20135399)
16. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant 2002; 16: 102-106 (Pubitemid 34414057)
17. Lee JY, Hahn HJ, Son IJ, Suh KS, Yi NJ, Oh JM, Shin WG. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients. Pharmacotherapy 2006; 26: 1069-1077
18. Kishino S, Ohno K, Shimamura T, Furukawa H, Todo S. A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transplant 2006; 20: 443-449 (Pubitemid 43983821)
19. Hashimoto Y, Sasa H, Shimomura M, Inui K. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. Pharm Res 1998; 15: 1609-1613 (Pubitemid 28465749)
20. Powis G, Jardine I, Van Dyke R, Weinshilboum R, Moore D, Wilke T, Rhodes W, Nelson R, Benson L, Szumlanski C. Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage. Drug Metab Dispos 1988; 16: 582-589 (Pubitemid 18196688)
21. Ninomiya M, Harada N, Shiotani S, Hiroshige S, Minagawa R, Soejima Y, Suehiro T, Nishizaki T, Shimada M, Sugimachi K. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation. Transpl Int 2003; 16: 814-819 (Pubitemid 37509418)
22. Oyama T, Sadamori H, Matsukawa H, Murata H, Umeda Y, Watanabe Y, Ozaki M, Iwagaki H, Tanaka N, Yagi T. Small liver graft regenerates through immediate increase of HGF and IL-6-possible involvement of sinusoidal tensile/shear stress in small liver graft. Hepatogastroenterology 2007; 54: 2078-2083
23. Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 2000; 32: 49-55 (Pubitemid 30432365)
24. Donato MT, Gómez-Lechón MJ, Jover R, Nakamura T, Castell JV. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. J Pharmacol Exp Ther 1998; 284: 760-767 (Pubitemid 28086669)
25. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993; 44: 707-715 (Pubitemid 23317282)
26. Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 2005; 28: 1805-1808 (Pubitemid 41324160)
27. Butani L, Berg G, Makker SP. Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. Transplantation 2002; 73: 159-160 (Pubitemid 34094708)
28. Hosohata K, Masuda S, Katsura T, Takada Y, Kaido T, Ogura Y, Oike F, Egawa H, Uemoto S, Inui K. Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. Drug Metab Dispos 2009; 37: 821-826